For now, it is available only for research purposes
Tirzepatide is generally studied as a dual GIP and GLP-1 receptor agonist, while Retatrutide is studied as a triple receptor agonist involving GIP, GLP-1, and glucagon receptor pathways
Improved glucose control: Targeting GLP-1 and GIP receptors, retatrutide demonstrates promising results in improving insulin sensitivity and glucose regulation
Below are some additional tips for the proper storage of retatrutide: Avoid storing in the bathroom: Indoor environmental moisture can compromise the peptides stability
RETATRUTIDE (RETA) Third-Party Tested COA Available Retatrutide is a synthetic peptide engineered to interact with multiple metabolic receptor systems including GLP-1, GIP, and glucagon receptors
All products sold by Regentide are for laboratory and research use only (RUO)